Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | TOP2A | P11388 | 2/20 | 0.41 |
| ▸ | TOP2B | Q02880 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | FAAH | O00519 | 1/20 | 0.38 |
| ▸ | TPSAB1 | Q15661 | 2/20 | 0.38 |
| ▸ | PLG | P00747 | 1/20 | 0.38 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.38 |
| ▸ | CARM1 | Q86X55 | 2/20 | 0.37 |
| ▸ | PRMT6 | Q96LA8 | 2/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23417763 | 0.89 | CYP4F2 (0.45) | TOP2ATOP2BLMNAHTTFAAH | |
| SCHEMBL29344415 | 0.85 | TOP2A (0.40) | ALOX15TOP2ATOP2BLMNATPSAB1 | |
| SCHEMBL26428983 | 0.77 | ADRB2 (0.50) | ALOX15TOP2ATOP2BLMNAHTT | |
| SCHEMBL15110131 | 0.77 | CYP4F2 (0.54) | ALOX15LMNAHTTFAAHHSD17B10 | |
| SCHEMBL23417714 | 0.76 | KDM4E (0.44) | TOP2ATOP2BLMNAHTTTPSAB1 | |
| SCHEMBL29344081 | 0.75 | GAA (0.46) | TOP2ATOP2BLMNATPSAB1PLG | |
| SCHEMBL24668212 | 0.74 | ALOX15 (0.54) | ALOX15LMNAHTTPRSS1CARM1 | |
| SCHEMBL24716099 | 0.74 | CYP4F2 (0.48) | TOP2ATOP2BLMNAHTTFAAH | |
| SCHEMBL23417785 | 0.74 | TOP2A (0.41) | ALOX15TOP2ATOP2BLMNATPSAB1 | |
| SCHEMBL26428603 | 0.74 | CARM1 (0.48) | ALOX15FAAHCARM1PRMT6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240238436-A1 | COMPOSITIONS INCLUDING CONJUGATED THERAPY ENHANCERS | BIOHAVEN THERAPEUTICS LTD. (VG) | 2024-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240238436-A1 | COMPOSITIONS INCLUDING CONJUGATED THERAPY ENHANCERS | LGMN, LPXN, LY96 | ALOX15 1607/4885TOP2A 681/4885TOP2B 1152/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.